Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient

Multiple Sclerosis

Volumn 20, Issue 10, 2014, Pages 1404-1406

  Kravljanac, Ruzica ^a   Martinovi, Vanja ^a   Dujmovi, Irena ^a   Djuri, Milena ^a   Kuzmanovi, Milo͉ ^a   Weinshenker, Brian G ^b   Drulovi, Jelena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b MAYO CLINIC   (United States)

Author keywords

Anti aquaporin 4 antibody; MRI; Neuromyelitis optica; Paediatric patient

Indexed keywords

ACICLOVIR; AQUAPORIN 4 ANTIBODY; CEFTRIAXONE; CORTICOSTEROID; DIURETIC AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; SODIUM ION; STEROID; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ANOREXIA; ARTICLE; ARTIFICIAL VENTILATION; BABINSKI REFLEX; CASE REPORT; CEREBELLAR ATAXIA; CONSCIOUSNESS DISORDER; DIARRHEA; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DIVERGENT STRABISMUS; DRUG DOSE REDUCTION; DYSPHAGIA; FEMALE; FEVER; HEMIPARESIS; HICCUP; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; LETHARGY; LIMB WEAKNESS; MAINTENANCE THERAPY; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PATIENT HISTORY OF THERAPY; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; RESPIRATORY FAILURE; SODIUM BLOOD LEVEL; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; VERTIGO; VOMITING; WEIGHT REDUCTION; BLOOD; FLUID THERAPY; IMMUNOLOGY; INAPPROPRIATE ADH SYNDROME; NEUROMYELITIS OPTICA; PREDICTIVE VALUE; RECURRENT DISEASE; SEROLOGY; TREATMENT OUTCOME;

ADOLESCENT; AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; FLUID THERAPY; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INAPPROPRIATE ADH SYNDROME; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA; PREDICTIVE VALUE OF TESTS; RECURRENCE; SEROLOGIC TESTS; TREATMENT OUTCOME;

EID: 84945284265     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514536254     Document Type: Article

References (10)

1. Schwartz WB, Bennett W, Curelop S, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957; 23: 529-542.
2. Lotze TE, Northrop JL, Hutton GJ, et al. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008; 122: e1039-1047.
3. Iorio R, Lucchinetti CF, Lennon VA, et al. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology 2011; 77: 1644-1646.
4. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100.
5. Khurana M. Disorders of salt and water balance. In: Kiessling SG, Somers MJG (eds) Pediatric nephrology in the ICU. Berlin; Heidelberg: Springer-Verlag, 2009, pp.1-18.
6. Nakajima H, Fujiki Y, Ito T, et al. Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation. Case Rep Neurol 2011; 3: 263-267.
7. Breningstall G. An 11-year-old girl with syndrome of inappropriate antidiuretic hormone secretion. Semin Pediatr Neurol 1999; 6: 202-208.
8. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
9. Trebst C, Jarius S, Berthele A, et al. Neuromyelitis Optica Study Group (NEMOS). Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014; 261: 1-16.
10. Greenberg BM, Graves D, Remington G, et al. Rituximab dosing and monitoring strategies in neuromyelitis optica patients: Creating strategies for therapeutic success. Mult Scler 2012; 18: 1022-1026.